CEPHEID 4
4 · CEPHEID · Filed Feb 13, 2015
Insider Transaction Report
Form 4
CEPHEIDCPHD
MORTON DEAN O
Director
Transactions
- Exercise/Conversion
Common Stock
2015-02-11$9.26/sh+6,250$57,875→ 22,584 total - Sale
Common Stock
2015-02-11$57.52/sh−6,250$359,531→ 16,334 total - Exercise/Conversion
Common Stock
2015-02-13$9.26/sh+6,250$57,875→ 22,584 total - Sale
Common Stock
2015-02-13$59.50/sh−6,250$371,875→ 16,334 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-02-11−6,250→ 6,250 totalExercise: $9.26From: 2010-04-29Exp: 2016-04-29→ Common Stock (6,250 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-02-13−6,250→ 0 totalExercise: $9.26From: 2010-04-29Exp: 2016-04-29→ Common Stock (6,250 underlying)
Holdings
- 82,500(indirect: See Footnote)
Common Stock
- 93,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
- [F2]The Reporting Person is a general partner of MDLC Partners, a California limited partnership ("MDLC"). As a general partner, the Reporting Person shares voting and investment power of the shares held by MDLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Shares are held by the Dean and Lavon Morton Trust dated 9/20/79, of which the Reporting Person is a trustee.